Published in Br Med Bull on January 01, 1992
Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest (1996) 3.74
Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med (1996) 3.33
Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J Clin Invest (1997) 2.68
Requirement for CD8+ T cells in the development of airway hyperresponsiveness in a marine model of airway sensitization. J Exp Med (1996) 1.49
Two highly homologous ribonuclease genes expressed in mouse eosinophils identify a larger subgroup of the mammalian ribonuclease superfamily. Proc Natl Acad Sci U S A (1996) 1.19
Interleukin-6 aborts lymphopoiesis and elevates production of myeloid cells in systemic lupus erythematosus-prone B6.Sle1.Yaa animals. Blood (2009) 1.17
Inhibition of aldose reductase prevents experimental allergic airway inflammation in mice. PLoS One (2009) 1.11
Lung eosinophilia is dependent on IL-5 and the adhesion molecules CD18 and VLA-4, in a guinea-pig model. Immunology (1995) 0.92
Ozone modulates IL-6 secretion in human airway epithelial and smooth muscle cells. Am J Physiol Lung Cell Mol Physiol (2009) 0.91
LPS-induced 111In-eosinophil accumulation in guinea-pig skin: evidence for a role for TNF-alpha. Immunology (1995) 0.81
Investigation of the endogenous chemoattractants involved in 111In-eosinophil accumulation in passive cutaneous anaphylactic reactions in the guinea-pig. Br J Pharmacol (1994) 0.79
Automated quantitation of circulating neutrophil and eosinophil activation in asthmatic patients. Thorax (2000) 0.79
Molecular biology and genetics of allergy and asthma. Arch Dis Child (1998) 0.78
The effect of ozone exposure on the release of eicosanoids in guinea-pig BAL fluid in relation to cellular damage and inflammation. Mediators Inflamm (1997) 0.77
Chemokines: structure, receptors and functions. A new target for inflammation and asthma therapy? Mediators Inflamm (1996) 0.76
New perspectives on basic mechanisms in lung disease. 3. Drug intervention in asthma: present and future. Thorax (1993) 0.75
Blood eosinophils, leukotriene C4 generation, and bronchial hyperreactivity in formerly preterm infants. Arch Dis Child (1994) 0.75
Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest (1991) 3.88
Interleukin-2- and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa. Immunology (1993) 3.20
Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma. J Allergy Clin Immunol (1997) 2.28
IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entity. Am J Respir Crit Care Med (1996) 1.93
Expression and generation of interleukin-8, IL-6 and granulocyte-macrophage colony-stimulating factor by bronchial epithelial cells and enhancement by IL-1 beta and tumour necrosis factor-alpha. Immunology (1992) 1.93
The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences. Immunol Today (1999) 1.67
Late response to allergen is associated with increased concentrations of tumor necrosis factor-alpha and IL-5 in induced sputum. J Allergy Clin Immunol (1997) 1.65
Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J Immunol (1997) 1.59
Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product. J Immunol (1995) 1.42
Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon gamma) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. Am J Respir Cell Mol Biol (1995) 1.42
Relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma. Am J Respir Crit Care Med (1997) 1.39
Identification of cyclic AMP phosphodiesterases 3, 4 and 7 in human CD4+ and CD8+ T-lymphocytes: role in regulating proliferation and the biosynthesis of interleukin-2. Br J Pharmacol (1996) 1.23
Immunotherapy for allergic rhinitis. Clin Exp Allergy (2011) 1.13
Increased expression of mRNA encoding RANTES and MCP-3 in the bronchial mucosa in atopic asthma. Eur Respir J (1996) 1.09
Effect of oral glucocorticoid treatment on serum inflammatory markers in acute asthma. Arch Dis Child (2000) 1.04
Epidemiological associations of allergy, IgE and cancer. Clin Exp Allergy (2013) 1.01
Kinetics of cell infiltration and cytokine messenger RNA expression after intradermal challenge with allergen and tuberculin in the same atopic individuals. J Allergy Clin Immunol (1994) 1.00
Human eosinophils express messenger RNA encoding RANTES and store and release biologically active RANTES protein. Eur J Immunol (1996) 0.99
Costimulation through CD86 is involved in airway antigen-presenting cell and T cell responses to allergen in atopic asthmatics. J Immunol (1998) 0.98
Inhaled glucocorticoid therapy of childhood asthma is associated with reduced peripheral blood T cell activation and 'Th2-type' cytokine mRNA expression. Pediatrics (1997) 0.95
Effects of rapamycin, cyclosporin A, and dexamethasone on interleukin 5-induced eosinophil degranulation and prolonged survival. Allergy (1997) 0.94
Activated peripheral blood CD4 and CD8 T-lymphocytes in child asthma: correlation with eosinophilia and disease severity. Pediatr Allergy Immunol (1994) 0.90
Retail sales of inhalation devices in European countries: so much for a global policy. Respir Med (2011) 0.90
An annexin 1 (ANXA1)-derived peptide inhibits prototype antigen-driven human T cell Th1 and Th2 responses in vitro. Clin Exp Allergy (2001) 0.89
Serum interleukin 5 concentrations in atopic and non-atopic patients with glucocorticoid-dependent chronic severe asthma. Thorax (1994) 0.87
Sphingosine-1-phosphate induces pro-remodelling response in airway smooth muscle cells. Allergy (2014) 0.84
T cells from human allergen-induced late asthmatic responses express IL-12 receptor beta 2 subunit mRNA and respond to IL-12 in vitro. J Immunol (2000) 0.84
Survival of mice with NC carcinoma is unchanged by drugs that are thought to inhibit thromboxane synthesis or increase prostacyclin formation. Br J Cancer (1986) 0.84
Interleukin-25 promotes basic fibroblast growth factor expression by human endothelial cells through interaction with IL-17RB, but not IL-17RA. Clin Exp Allergy (2012) 0.83
Allergen-induced proliferation and interleukin-5 production by bronchoalveolar lavage and blood T cells after segmental allergen challenge. Am J Respir Crit Care Med (1998) 0.83
Direct comparison of the dynamics of IL-25- and 'allergen'-induced airways inflammation, remodelling and hypersensitivity in a murine asthma model. Clin Exp Allergy (2014) 0.83
Resistin-like molecule-β is a human airway remodelling mediator. Eur Respir J (2011) 0.83
T cells producing the anti-inflammatory cytokine IL-10 regulate allergen-specific Th2 responses in human airways. Allergy (2012) 0.83
The continuing enigma of non-atopic asthma. Clin Exp Allergy (2005) 0.82
The topical glucocorticoids beclomethasone dipropionate and fluticasone propionate inhibit human T-cell allergen-induced production of IL-5, IL-3 and GM-CSF mRNA and protein. Clin Exp Allergy (2001) 0.82
Peripheral blood markers: evaluation of inflammation in asthma. Eur Respir J Suppl (1998) 0.82
Polymerase chain reaction quantification of cytokine messenger RNA expression in peripheral blood mononuclear cells of patients with acute exacerbations of asthma: effect of glucocorticoid therapy. Clin Exp Allergy (1994) 0.82
T lymphocytes in asthma: bronchial versus peripheral responses. J Allergy Clin Immunol (2000) 0.81
Effect of grass pollen immunotherapy with Alutard SQ on quality of life in seasonal allergic rhinoconjunctivitis. Allergy (2007) 0.81
Increased expression of high affinity IgE (FcepsilonRI) receptor-alpha chain mRNA and protein-bearing eosinophils in human allergen-induced atopic asthma. Am J Respir Crit Care Med (1998) 0.80
The role of cellular immunology in asthma. Eur Respir J Suppl (1991) 0.80
Molecular concepts of IgE-initiated inflammation in atopic and nonatopic asthma. Allergy (1998) 0.80
Interleukin-5 mRNA in mucosal bronchial biopsies from asthmatic subjects. Int Arch Allergy Appl Immunol (1991) 0.79
A novel technique to explore the functions of bronchial mucosal T cells in chronic obstructive pulmonary disease: application to cytotoxicity and cytokine immunoreactivity. Clin Exp Immunol (2010) 0.78
Elevated interleukin-4 secretion by T lymphocytes: a feature of atopy or of asthma? Clin Exp Allergy (1995) 0.78
Unstimulated basophils in atopic and nonatopic subjects express intracellular interleukin-4: detection by flow cytometry. Allergy (1998) 0.77
Clinical response to cyclosporin in chronic severe asthma is associated with reduction in serum soluble interleukin-2 receptor concentrations. Eur Respir J (1995) 0.76
Inhibition of re-expression of surface CD4, but not CD8, on activated human T-lymphocytes by the immunosuppressive drugs dexamethasone and cyclosporine A: correlation with inhibition of proliferation. Int J Immunopharmacol (1996) 0.75
Glucocorticoid unresponsiveness in severe ulcerative colitis. Gut (1999) 0.75
Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT). NPJ Prim Care Respir Med (2016) 0.75
Oral steroids and inflammatory markers in asthma. Arch Dis Child (2001) 0.75
Effect of fluticasone on the elastase:antielastase profile of the normal lung. Eur J Clin Invest (2002) 0.75
Homoeopathy and hayfever. Clin Exp Allergy (1991) 0.75
Interactions of astringent substances. Chem Senses (1994) 0.75
Can clinical response to cyclosporin in chronic severe asthma be predicted by an in vitro T-lymphocyte proliferation assay? Eur Respir J (1996) 0.75
Genetics and regulation of the human immune response. Report on a symposium held at Ringberg Castle, Rottach-Egern a. Tegernsee. Clin Exp Allergy (1992) 0.75
T lymphocytes in allergen-induced late-phase reactions and asthma. Int Arch Allergy Appl Immunol (1989) 0.75
Intravenous immunoglobulin therapy for asthma: time for a closer look? Thorax (1997) 0.75
T cells, cytokines and asthma. J R Coll Physicians Lond (1994) 0.75
Lymphokines in asthma: are they there and can they be detected? Clin Exp Allergy (1991) 0.75
Finger clubbing and tumour necrosis factor alpha. Lancet (1990) 0.75